glp-1 and psoriatic arthritis Agonists Psoriasis: A Potential Novel Therapeutic Approach Glucagon-like peptide-1 receptor agonists in

Mecanismo de ao Estimula a secreo de insulina (glicose-dependente) Inibe a secreo de glucagon Retarda o esvaziamento gstrico Reduz o apetite via ao no hipotlamo Melhora o controle glicmico ps-prandial Pode contribuir com neuroproteo e sade cardiovascular Aplicaes teraputicas Relao com a indstria farmacutica Os medicamentos baseados em GLP-1 se tornaram uma das classes teraputicas de maior crescimento da indstria farmacutica global

A 2023 meta-analysis in the Journal of Vascular Surgery found that patients achieving sustained weight reduction showed improved limb volume measurements and reduced infection rates, hallmarks of improved lymphatic function

However, it hasnt yet received standalone FDA approval for weight lossdespite many clinical studies showing it is effective for that purpose

Its emergence challenges existing treatment algorithms and underscores the importance of mechanism based innovation in addressing the growing global burden of diabetes and obesity